Hong Kong Tariffs and US Tariffs on China, 2026

Chinese and United States national flags flying side by side against a blue sky

Key takeaways

  • As of October 2026, goods from China pay the MFN rate, any original Section 301 duty for their HTSUS line and a new 12.5% Section 301 forced labor duty that applies to entries from July 24, 2026, with listed exemptions.

  • Hong Kong products face the same 12.5% Section 301 forced labor duty in their own right, and since 2020 they must be marked with China as the country of origin.

  • The IEEPA tariffs of 2025, including the fentanyl and reciprocal duties on China and Hong Kong, were terminated on February 20, 2026 after the Supreme Court ruled that IEEPA does not authorize tariffs.

  • Duty-free de minimis treatment remains suspended for all countries, so low-value parcels from China and Hong Kong need an entry and pay duties.

  • Hong Kong itself is a free port that charges no customs tariff on imports, only excise duty on four types of goods.

Hong Kong tariffs and US tariffs on China changed more in 2026 than in any year since the first Section 301 actions in 2018. The emergency tariffs that dominated 2025 are gone, a temporary surcharge came and went, and a new Section 301 duty now applies to products of both China and Hong Kong. As of October 2026, most goods from either place pay three layers at most: the normal HTSUS duty, any original Section 301 China duty for that product, and a 12.5% Section 301 forced labor duty, unless an exemption applies.

This guide explains each layer, how Hong Kong is treated, what happened to de minimis, how tariffs flow into sourcing costs and how to confirm the rate for a specific product. Every status point below was checked against official US government sources in October 2026. Tariff rules change through Federal Register notices with little warning, so confirm the rate for your exact HTSUS line and entry date with your licensed customs broker before you price, quote or ship.

What are the current US tariffs on China?

The current tariffs on China, as of October 2026, are built from the regular duty rate plus up to two Section 301 layers, with Section 232 tariffs replacing the forced labor layer for products such as patented pharmaceuticals and metals. The emergency tariffs imposed under the International Emergency Economic Powers Act (IEEPA) are no longer collected.

The table below summarizes the layers that matter for most healthcare and life science importers. It is a map of where to look, not a rate quote for any product.

Tariff layer

Status as of October 2026

Applies to

What to confirm

MFN (general) duty in HTSUS chapters 1 to 97

In force

All products of China and Hong Kong

The 10-digit HTSUS line and its general rate

Original Section 301 China actions (Lists 1 to 4 and the four-year review increases)

In force

Products of China on the covered lists

Whether your line is listed and whether one of the 178 exclusions applies

Section 301 forced labor action

In force for entries on or after July 24, 2026

Products of China and products of Hong Kong at 12.5%

Whether your line is in the exemption annexes

Section 232 tariffs

In force for covered products

Products such as patented pharmaceuticals, steel, aluminum and copper, from any country

Whether your product is in a Section 232 annex

IEEPA fentanyl and reciprocal tariffs

Terminated February 20, 2026

Applied to China and Hong Kong in 2025

Whether duties paid on past entries can be recovered

Section 122 temporary surcharge

Imposed February 2026 for 150 days, no longer in force

Most imports during its term

How it affects entries made while it applied

The practical takeaway is that one Chinese product can carry very different totals depending on its classification. A medical instrument with a free MFN rate that is not on any original Section 301 list may now pay only the 12.5% forced labor duty. A product on one of the original lists pays that Section 301 rate as well, and the two stack.

The 12.5% Section 301 forced labor duty

The newest layer comes from a USTR notice of action published in the Federal Register on July 28, 2026. It closed 60 Section 301 investigations into whether trading partners impose and enforce a ban on imports made with forced labor. For China, USTR determined to impose 12.5% tariffs on products of China, except as provided in the notice's exemption annexes. The duties apply to goods entered for consumption, or withdrawn from warehouse, on or after 12:01 a.m. eastern time on July 24, 2026.

Three details matter for healthcare importers. First, the exemptions include articles subject to Section 232 tariffs, so a patented medicine under the Section 232 pharmaceutical action does not also pay this duty. Second, the exemption list kept certain chemical products only for pharmaceutical applications, which means end use can decide whether a chemical pays. Third, the HTSUS note added by the notice says products subject to these new headings are also subject to other additional duties in the same part of Chapter 99, so the forced labor duty stacks on top of the original China Section 301 duties rather than replacing them.

The original Section 301 China tariffs

The Section 301 actions from 2018 and 2019 rest on a different statute from IEEPA and were not affected by the Supreme Court decision. USTR lists them as four trade actions, known as Lists 1 to 4, on its Section 301 tariff actions page. Rates differ by list and by product.

The 2024 four-year review raised rates on several medical products. The final modifications notice of September 18, 2024 increased the rate on syringes and needles to 100% in 2024 and on medical gloves to 50% in 2025 and 100% in 2026. It also raised rates on certain facemasks and respirators. If you buy disposables, gloves or injection devices from China, check these lines first because they now carry some of the highest rates in the schedule.

USTR also keeps 178 product exclusions from the original actions. A notice published on December 1, 2025 extended them through 11:59 p.m. eastern daylight time on November 9, 2026. Unless USTR extends them again, products that rely on these exclusions will pay the full Section 301 rate on entries after that time. Watch the Federal Register in early November 2026 if any of your lines use headings 9903.88.69 or 9903.88.70.

What happened to the IEEPA tariffs

In 2025 the largest China duties came from IEEPA, first as a fentanyl-related tariff and then as reciprocal tariffs that changed several times during the year. Our earlier explainer on US-China temporary tariff relief covers how those rates moved. On February 20, 2026 the Supreme Court held in Learning Resources, Inc. v. Trump that IEEPA does not authorize the President to impose tariffs. A CBP rule published on June 24, 2026 explains that Executive Order 14389 of the same day terminated the additional duties imposed under IEEPA.

The administration replaced them for 150 days with a 10% surcharge under Section 122 of the Trade Act of 1974, and that period ended in July 2026. If you paid IEEPA duties on 2025 or early 2026 entries, ask your broker whether those entries are eligible for a refund and what CBP requires to process it.

Are there US tariffs on goods from Hong Kong?

Yes. As of October 2026, goods from Hong Kong pay the regular HTSUS duty plus the 12.5% Section 301 forced labor duty, unless an exemption applies. USTR treated Hong Kong as its own investigated economy in the July 2026 notice and determined to impose 12.5% tariffs on products of Hong Kong, on the same exemption terms as China.

Hong Kong tariffs to US buyers have a history that explains the confusion. In July 2020, Executive Order 13936 ended differential treatment of Hong Kong under several US laws. CBP then announced in a notice published on August 11, 2020 that goods produced in Hong Kong may no longer be marked "Hong Kong" and must be marked "China." That rule is about marking, not about which tariffs apply.

In 2025 the link went further. CBP's February 5, 2025 notice implementing the first IEEPA tariff on China stated that products of China include products of Hong Kong under Executive Order 13936, so the 2025 emergency tariffs applied to both. Those IEEPA tariffs have now ended, and the 2026 forced labor duty names Hong Kong separately.

The tariff from Hong Kong to US entries therefore depends on true origin, not on the port of export. A product manufactured in mainland China and shipped through Hong Kong is a product of China. A product substantially transformed in Hong Kong is a product of Hong Kong. Whether a Hong Kong origin product is caught by the original 2018 and 2019 China Section 301 lists is a classification and origin question to settle with your broker before the first entry, because those actions are written for products of China.

Does Hong Kong have its own import tariffs?

Hong Kong does not charge customs tariffs on imports or exports. The Hong Kong Customs and Excise Department states that Hong Kong is a free port that does not levy any customs tariff on imports and exports, with no tariff quota, surcharge, value added tax or general services tax. Excise duties apply only to four types of dutiable commodities: liquor, tobacco, hydrocarbon oil and methyl alcohol.

So when people ask does Hong Kong have tariffs, the answer for most medical, laboratory and research goods is no on the Hong Kong side. That does not remove other requirements. Import and export declarations, licensing for controlled items and rules for pharmaceuticals or dangerous goods still apply in Hong Kong, so a consignee there should confirm documentation for regulated products.

The tariffs on Hong Kong that most US importers worry about are US duties collected when Hong Kong origin goods enter the United States. Those are the layers described above.

Is de minimis still available for China and Hong Kong?

No. Duty-free de minimis treatment for shipments valued at $800 or less remains suspended for all countries. The June 2026 CBP rule explains that Executive Order 14388 of February 20, 2026 continued the suspension, including for shipments sent through the international postal network, even after the IEEPA tariffs ended. CBP also published an interim final rule that suspends the exemption indefinitely for mail shipments and creates a postal informal entry process, effective July 24, 2026.

Separately, legislation enacted on July 4, 2025 terminates the statutory de minimis exemption effective July 1, 2027. For importers of low-value samples, spare parts or consumables from China or Hong Kong, the practical result is that every shipment needs an entry and pays applicable duties, including Section 301 layers. Small parcels sent by express carriers are entered through the carrier or a broker, so check how they bill duties and brokerage before you rely on frequent small shipments.

How do China tariffs affect the cost of sourcing products?

China tariffs raise the landed cost of each unit by the combined duty rate applied to the customs value, plus any brokerage, bond and compliance costs that come with more complex entries. Because rates differ so much by product, the effect on China import tariffs cost of sourcing calculations is product specific, and averages can mislead.

A simple way to model the effect is to build the landed cost line by line:

  1. Start with the customs value, usually the transaction value on the commercial invoice.

  2. Add the MFN duty for the 10-digit HTSUS line.

  3. Add the original Section 301 rate if the line is on a list and no exclusion applies.

  4. Add the 12.5% forced labor duty unless the line is exempt or covered by Section 232.

  5. Add merchandise processing and harbor maintenance fees where they apply, brokerage, and the cost of your customs bond.

  6. Add freight, insurance and any cold chain costs, which do not change with the tariff but often grow when shipments are held for review.

Here is an illustrative example with hypothetical figures, not a rate for any real product. A $10,000 shipment of laboratory consumables with a free MFN rate, no original Section 301 coverage and no exemption would pay about $1,250 in forced labor duty. If the same consumables were on an original Section 301 list at 25%, the duty would be about $3,750. The goods are the same, but classification changes the result by $2,500.

Tariffs also change sourcing decisions beyond the duty bill. Many buyers compare alternative origins, but moving production only helps if the new origin is real under customs rules, since final assembly alone may not change origin. Many other origins were part of the same 60 investigations and face a Section 301 forced labor rate of 10% or 12.5% depending on the economy, so the savings from shifting away from China can be smaller than expected. For temperature-sensitive goods, a cheaper origin with a longer or less reliable lane may cost more in excursions than it saves in duty. Our guide to tariffs and duties for healthcare products explains the wider cost picture.

How do importers confirm the tariff on a Chinese product?

Importers confirm the tariff on a Chinese product by classifying it to a 10-digit HTSUS line, checking that line and its Chapter 99 references in the current HTSUS, confirming origin, and having a licensed customs broker validate the result for the planned entry date. A short routine keeps this manageable:

  • Classify the product using its composition, function and use, and keep the reasoning in the file. Our guide to HS codes for healthcare and life sciences covers common product groups.

  • Search the line in the official HTSUS search tool from the US International Trade Commission and follow every Chapter 99 footnote, since Section 301 and Section 232 duties are reported through 9903 headings.

  • Confirm origin from manufacturing records, not from the shipping address. Hong Kong transshipment does not change Chinese origin.

  • Check the exemption annexes in the July 2026 Section 301 notice and the list of original Section 301 exclusions with their November 9, 2026 end date.

  • Check whether a Section 232 action covers the product, especially for patented pharmaceuticals and products containing steel, aluminum or copper.

  • For uncertain cases, request a binding ruling from CBP. Published rulings in CBP's CROSS database can guide you, but they apply to the facts of the ruled product.

Re-check the rate when a new Federal Register notice is published, when an exclusion is about to expire and before every new product launch. Rates confirmed in October 2026 can change before goods arrive in November.

Planning shipments from China and Hong Kong

Healthcare and life science shipments from China often combine tariff questions with time-sensitive handling. A shipment of reagents held because an exemption claim lacks end-use documentation still needs its temperature maintained while the question is resolved. Preparing the classification, origin evidence and Chapter 99 lines before pickup reduces that risk.

Mercury's customs brokerage team can review classifications and current tariff layers for products from China and Hong Kong before they ship, and an active US customs bond is required for formal entries. For lane planning and regulatory context on this corridor, see our US-China healthcare logistics guide.

Share on Linkedin
Share on X
Share on Facebook

From our blog

From our blog